12‐month real world data for Nusinersen in type I Spinal Muscular Atrophy patients
Latest Information Update: 26 Jun 2019
At a glance
- Drugs Nusinersen (Primary)
- Indications Spinal muscular atrophy
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 26 Jun 2019 New trial record
- 22 Jun 2019 One year real world data (n=85) published in the Annals of Neurology.